title: Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?
abstract: Human immunodeficiency virus type 1 (HIV-1) establishes latency in resting memory CD4+ T cells and cells of myeloid lineage. In contrast to the T cells, cells of myeloid lineage are resistant to the HIV-1 induced cytopathic effect. Cells of myeloid lineage including macrophages are present in anatomical sanctuaries making them a difficult drug target. In addition, the long life span of macrophages as compared to the CD4+ T cells make them important viral reservoirs in infected individuals especially in the late stage of viral infection where CD4+ T cells are largely depleted. In the past decade, HIV-1 persistence in resting CD4+ T cells has gained considerable attention. It is currently believed that rebound viremia following cessation of combination anti-retroviral therapy (cART) originates from this source. However, the clinical relevance of this reservoir has been questioned. It is suggested that the resting CD4+ T cells are only one source of residual viremia and other viral reservoirs such as tissue macrophages should be seriously considered. In the present review we will discuss how macrophages contribute to the development of long-lived latent reservoirs and how macrophages can be used as a therapeutic target in eradicating latent reservoir.
authors.affiliation: Department of Biology, SBA School of Science and Engineering, Lahore University of Management Sciences, Lahore 54792, Pakistan. wazim_cemb@hotmail.com.
authors.forename: Wasim
authors.initials: W
authors.lastname: Abbas
authors.affiliation: Department of Biology, SBA School of Science and Engineering, Lahore University of Management Sciences, Lahore 54792, Pakistan. m.tariq@lums.edu.pk.
authors.forename: Muhammad
authors.initials: M
authors.lastname: Tariq
authors.affiliation: Laboratory of Drug Discovery and Structural Biology, Health Biotechnology Division, National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad 38000, Pakistan. hamzamgondal@gmail.com.
authors.forename: Mazhar
authors.initials: M
authors.lastname: Iqbal
authors.affiliation: Department of Virology, University of Franche-Comté, CHRU Besançon, UPRES EA4266 Pathogens and Inflammation, SFR FED 4234, 25030 Besançon, France. amit.aiims2005@gmail.com.
authors.forename: Amit
authors.initials: A
authors.lastname: Kumar
authors.affiliation: Department of Virology, University of Franche-Comté, CHRU Besançon, UPRES EA4266 Pathogens and Inflammation, SFR FED 4234, 25030 Besançon, France. georges.herbein@univ-fcomte.fr.
authors.forename: Georges
authors.initials: G
authors.lastname: Herbein
mesh_terms: D002353:Carrier State / Q000628:therapy* / Q000821:virology*; D015658:HIV Infections / Q000628:therapy* / Q000821:virology*; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D008264:Macrophages / Q000821:virology*; D017735:Virus Latency
references.citation: Sci Rep. 2014;4:4450
references.pmid: 24658403
references.citation: Virology. 2008 Mar 15;372(2):300-12
references.pmid: 18054979
references.citation: J Leukoc Biol. 2012 Dec;92(6):1147-54
references.pmid: 22802445
references.citation: Trends Immunol. 2012 Nov;33(11):554-62
references.pmid: 22867874
references.citation: Blood. 1993 Dec 1;82(11):3392-400
references.pmid: 7902137
references.citation: Nucleic Acids Res. 2014 Apr;42(8):4962-71
references.pmid: 24623795
references.citation: Trends Immunol. 2008 Feb;29(2):61-7
references.pmid: 18178131
references.citation: J Antimicrob Chemother. 2002 Sep;50(3):309-11
references.pmid: 12205054
references.citation: Retrovirology. 2006;3:7
references.pmid: 16412247
references.citation: Cell Host Microbe. 2014 Dec 10;16(6):711-21
references.pmid: 25467409
references.citation: AIDS Res Hum Retroviruses. 2015 Jan;31(1):36-44
references.pmid: 25257573
references.citation: Nat Med. 2014 May;20(5):480-1
references.pmid: 24804757
references.citation: J Virol. 2011 Oct;85(19):10399-403
references.pmid: 21795348
references.citation: Nature. 2008 Jan 24;451(7177):425-30
references.pmid: 18200009
references.citation: Lancet. 2013 Nov 2;382(9903):1525-33
references.pmid: 24152939
references.citation: Retrovirology. 2012;9:82
references.pmid: 23035819
references.citation: J Leukoc Biol. 2000 Sep;68(3):405-12
references.pmid: 10985258
references.citation: Blood. 2008 Nov 1;112(9):3679-87
references.pmid: 18728248
references.citation: Curr Opin HIV AIDS. 2015 Jan;10(1):18-28
references.pmid: 25415421
references.citation: J Leukoc Biol. 2015 Jan;97(1):61-9
references.pmid: 25359998
references.citation: Nature. 2004 Feb 26;427(6977):848-53
references.pmid: 14985764
references.citation: AIDS. 2001 Jan 5;15(1):17-22
references.pmid: 11192864
references.citation: Viruses. 2014 Apr;6(4):1837-60
references.pmid: 24759213
references.citation: J Leukoc Biol. 2010 Apr;87(4):557-67
references.pmid: 19843579
references.citation: JAMA. 1986 Nov 7;256(17):2365-71
references.pmid: 3490587
references.citation: Nature. 2011 Jun 30;474(7353):658-61
references.pmid: 21720370
references.citation: J Exp Med. 2006 Jan 23;203(1):41-6
references.pmid: 16418394
references.citation: Virology. 2007 May 10;361(2):325-34
references.pmid: 17222438
references.citation: Curr Med Chem. 2002 Nov;9(21):1893-903
references.pmid: 12369874
references.citation: J Virol. 2002 Jan;76(2):707-16
references.pmid: 11752161
references.citation: AIDS. 1998 Jul 30;12(11):1327-32
references.pmid: 9708412
references.citation: Nature. 2003 Jul 10;424(6945):213-9
references.pmid: 12853962
references.citation: Retrovirology. 2009;6:111
references.pmid: 19961595
references.citation: Curr Opin Infect Dis. 2013 Dec;26(6):561-6
references.pmid: 24152764
references.citation: Curr Opin Infect Dis. 2014 Feb;27(1):29-35
references.pmid: 24296585
references.citation: Nature. 1990 Jan 4;343(6253):85-9
references.pmid: 2296295
references.citation: Cell Host Microbe. 2015 Jan 14;17(1):98-106
references.pmid: 25532805
references.citation: AIDS. 2014 Mar 13;28(5):667-77
references.pmid: 24451159
references.citation: J Exp Med. 1988 Apr 1;167(4):1428-41
references.pmid: 3258626
references.citation: Lancet. 2014 Jul 19;384(9939):258-71
references.pmid: 24907868
references.citation: Nature. 1998 Sep 10;395(6698):189-94
references.pmid: 9744279
references.citation: J Leukoc Biol. 2010 Apr;87(4):599-608
references.pmid: 20042468
references.citation: J Infect Dis. 2009 Sep 15;200(6):947-54
references.pmid: 19678757
references.citation: AIDS. 2014 Sep 24;28(15):2175-87
references.pmid: 25144219
references.citation: PLoS Pathog. 2011 Sep;7(9):e1002221
references.pmid: 21966267
references.citation: J Virol. 1996 Jan;70(1):199-206
references.pmid: 8523526
references.citation: Curr Opin Virol. 2013 Aug;3(4):387-93
references.pmid: 23660570
references.citation: Eur J Immunol. 2011 Dec;41(12):3412-8
references.pmid: 22076814
references.citation: Tissue Antigens. 2013 Feb;81(2):61-71
references.pmid: 23330719
references.citation: PLoS One. 2011;6(8):e22982
references.pmid: 21886773
references.citation: Science. 2009 Mar 6;323(5919):1304-7
references.pmid: 19265012
references.citation: Nat Med. 1999 Sep;5(9):997-103
references.pmid: 10470075
references.citation: J Gen Virol. 1994 Dec;75 ( Pt 12):3393-400
references.pmid: 7527834
references.citation: J Infect Dis. 2008 Jan 15;197(2):309-18
references.pmid: 18173363
references.citation: Nature. 1995 Sep 28;377(6547):348-51
references.pmid: 7566090
references.citation: Cell. 2013 Oct 24;155(3):540-51
references.pmid: 24243014
references.citation: AIDS Res Hum Retroviruses. 2015 Jan;31(1):64-70
references.pmid: 25134819
references.citation: Antimicrob Agents Chemother. 2013 Mar;57(3):1262-9
references.pmid: 23263005
references.citation: Immunol Today. 1993 Mar;14(3):107-11
references.pmid: 8096699
references.citation: Lancet. 2013 Jun 15;381(9883):2109-17
references.pmid: 23541541
references.citation: Science. 1998 Apr 17;280(5362):427-31
references.pmid: 9545219
references.citation: N Engl J Med. 1998 Mar 26;338(13):853-60
references.pmid: 9516219
references.citation: J Leukoc Biol. 2003 Nov;74(5):719-25
references.pmid: 12960239
references.citation: Drug Metab Dispos. 2000 Jun;28(6):655-60
references.pmid: 10820137
references.citation: Virology. 2014 Apr;454-455:340-52
references.pmid: 24636252
references.citation: J Neurosci Res. 2009 Mar;87(4):1023-36
references.pmid: 18855943
references.citation: Curr HIV Res. 2008 Sep;6(5):388-400
references.pmid: 18855649
references.citation: J Virol. 1991 Jan;65(1):356-63
references.pmid: 1985204
references.citation: J Infect Dis. 1998 Aug;178(2):413-22
references.pmid: 9697721
references.citation: J Leukoc Biol. 2006 Nov;80(5):1127-35
references.pmid: 16923921
references.citation: J Immunol. 2000 Dec 1;165(11):6437-46
references.pmid: 11086083
references.citation: Nature. 2013 Oct 24;502(7472):559-62
references.pmid: 24048477
references.citation: Nat Rev Microbiol. 2009 Nov;7(11):798-812
references.pmid: 19834480
references.citation: J Med Virol. 2007 May;79(5):639-46
references.pmid: 17387751
references.citation: Curr HIV/AIDS Rep. 2010 Feb;7(1):37-43
references.pmid: 20425056
references.citation: J Leukoc Biol. 2003 Nov;74(5):635-41
references.pmid: 12960232
references.citation: J Immunol. 2007 May 15;178(10):6581-9
references.pmid: 17475889
references.citation: J Exp Med. 1997 Jan 6;185(1):55-64
references.pmid: 8996241
references.citation: Nat Rev Immunol. 2015 Jan;15(1):2-3
references.pmid: 25503915
references.citation: Retrovirology. 2010;7:32
references.pmid: 20380694
references.citation: Hum Vaccin Immunother. 2013 May;9(5):993-1001
references.pmid: 23370291
references.citation: Eur J Immunol. 1995 Dec;25(12):3418-24
references.pmid: 8566032
references.citation: Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL581-9
references.pmid: 15555424
references.citation: Curr HIV Res. 2014;12(3):201-12
references.pmid: 25026899
references.citation: Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):700-4
references.pmid: 8570619
references.citation: J Virol. 2008 Jul;82(13):6557-65
references.pmid: 18417568
references.citation: PLoS One. 2014;9(5):e96907
references.pmid: 24809719
references.citation: J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):114-9
references.pmid: 10737425
references.citation: Antiviral Res. 2010 Jan;85(1):119-41
references.pmid: 19782103
references.citation: J Infect Dis. 2001 Feb 1;183(3):417-24
references.pmid: 11133373
references.citation: Mol Ther. 2006 Aug;14(2):218-25
references.pmid: 16647883
references.citation: Nature. 2014 Aug 7;512(7512):35-6
references.pmid: 25043038
references.citation: Retrovirology. 2010;7:34
references.pmid: 20380698
references.citation: Nature. 2001 Apr 12;410(6830):834-8
references.pmid: 11298454
references.citation: Adv Virol. 2012;2012:574967
references.pmid: 22548060
references.citation: Antimicrob Agents Chemother. 1998 Dec;42(12):3157-62
references.pmid: 9835508
references.citation: Blood. 1999 Mar 15;93(6):1851-7
references.pmid: 10068657
references.citation: Cell. 2013 Oct 24;155(3):519-29
references.pmid: 24243012
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4641-6
references.pmid: 19273847
references.citation: Am J Med. 1988 Sep;85(3):289-91
references.pmid: 3414726
references.citation: Curr Opin HIV AIDS. 2015 Jan;10(1):43-8
references.pmid: 25402706
references.citation: J Leukoc Biol. 2006 Nov;80(5):1118-26
references.pmid: 17056765
references.citation: Neurobiol Dis. 2010 Mar;37(3):542-8
references.pmid: 20044002
references.citation: Trends Microbiol. 2014 Apr;22(4):173-5
references.pmid: 24641995
references.citation: J Virol. 2014 Feb;88(4):2025-34
references.pmid: 24307588
references.citation: J Immunol. 2014 Jun 1;192(11):5083-9
references.pmid: 24748497
references.citation: Curr HIV Res. 2014;12(2):97-110
references.pmid: 24862332
references.citation: PLoS Pathog. 2014 Oct;10(10):e1004467
references.pmid: 25356757
references.citation: J Neurosci Res. 2014 Feb;92(2):267-74
references.pmid: 24254728
references.citation: J RNAi Gene Silencing. 2010 May 29;6(1):386-400
references.pmid: 20628499
references.citation: Annu Rev Microbiol. 2008;62:425-43
references.pmid: 18785842
references.citation: Mediators Inflamm. 2013;2013:484378
references.pmid: 24453421
references.citation: J Innate Immun. 2014;6(6):716-26
references.pmid: 25138714
references.citation: J Neurovirol. 2015 Jun;21(3):242-8
references.pmid: 25236811
references.citation: Science. 1987 May 15;236(4803):819-22
references.pmid: 3646751
references.citation: AIDS Res Hum Retroviruses. 1990 Aug;6(8):1031-7
references.pmid: 1977427
references.citation: Antimicrob Agents Chemother. 2014;58(3):1713-22
references.pmid: 24379203
references.citation: Cell. 1995 Dec 1;83(5):793-802
references.pmid: 8521496
references.citation: Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007096
references.pmid: 22229121
references.citation: Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):658-63
references.pmid: 11136236
references.citation: J Leukoc Biol. 2010 Apr;87(4):541-3
references.pmid: 20356904
references.citation: Immunity. 2014 Jul 17;41(1):36-48
references.pmid: 25035952
references.citation: Curr HIV/AIDS Rep. 2014 Jun;11(2):186-94
references.pmid: 24729094
references.citation: Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):E3997-4006
references.pmid: 24082141
references.citation: Retrovirology. 2015;12:4
references.pmid: 25608886
references.citation: Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12655-60
references.pmid: 23852730
references.citation: J Leukoc Biol. 2003 Nov;74(5):642-9
references.pmid: 12960227
references.citation: Retrovirology. 2013;10:67
references.pmid: 23803414
references.citation: Curr HIV Res. 2011 Dec 1;9(8):552-3
references.pmid: 22409272
references.citation: Lancet. 2014 Sep 13;384(9947):1005-70
references.pmid: 25059949
references.citation: Neurobiol Dis. 2006 Jan;21(1):1-17
references.pmid: 16298136
references.citation: Mol Cell Ther. 2014 Apr 02;2:10
references.pmid: 26056579
references.citation: Nature. 1997 May 8;387(6629):188-91
references.pmid: 9144290
references.citation: Cell Host Microbe. 2008 Apr 17;3(4):245-52
references.pmid: 18342597
references.citation: J Infect Dis. 2006 Jul 1;194(1):11-9
references.pmid: 16741877
references.citation: Science. 1990 Jan 26;247(4941):454-6
references.pmid: 2405486
references.citation: PLoS One. 2013;8(1):e54349
references.pmid: 23372711
references.citation: Blood. 2005 Oct 15;106(8):2790-7
references.pmid: 15976177
references.citation: J Clin Invest. 1998 Jan 15;101(2):289-94
references.pmid: 9435299
references.citation: J Virol. 2004 Aug;78(15):7883-93
references.pmid: 15254161
references.citation: Curr HIV Res. 2006 Apr;4(2):199-208
references.pmid: 16611058
references.citation: J Virol. 2003 Jun;77(12):6700-8
references.pmid: 12767990
references.citation: J Leukoc Biol. 2010 Apr;87(4):621-6
references.pmid: 20130221
references.citation: J Clin Invest. 1991 Jan;87(1):27-30
references.pmid: 1985101
references.citation: Antimicrob Agents Chemother. 2011 Aug;55(8):3696-702
references.pmid: 21628534
references.citation: Nature. 2002 Aug 8;418(6898):646-50
references.pmid: 12167863
references.citation: AIDS Res Hum Retroviruses. 2002 Apr 10;18(6):427-34
references.pmid: 11958686
references.citation: Curr Infect Dis Rep. 2014 Mar;16(3):392
references.pmid: 24562540
references.citation: J Clin Immunol. 2013 Jan;33(1):302-6
references.pmid: 22961048
references.citation: Science. 1997 Jun 20;276(5320):1857-61
references.pmid: 9188531
references.citation: AIDS Res Hum Retroviruses. 2006 May;22(5):425-9
references.pmid: 16706619
references.citation: Retrovirology. 2009;6:51
references.pmid: 19486514
references.citation: Retrovirology. 2010;7:33
references.pmid: 20380696
references.citation: Nat Immunol. 2012 Mar;13(3):223-8
references.pmid: 22327569
references.citation: Antivir Ther. 2004 Aug;9(4):519-28
references.pmid: 15456083
references.citation: Blood. 2015 Mar 5;125(10):1611-22
references.pmid: 25527710
references.citation: Front Immunol. 2014 Oct 17;5:514
references.pmid: 25368618
references.citation: Clin Immunol Immunopathol. 1992 Nov;65(2):143-51
references.pmid: 1356673